AstraZeneca (AZN) shares rose 3.5% in premarket trading Friday after the British drugmaker reported stronger-than-expected third-quarter earnings, driven by robust growth in its oncology business. Core earnings per share came in at $2.79 (+19% at constant exchange rate), b
AstraZeneca (AZN) shares rose 3.5% in premarket trading Friday after the British drugmaker reported stronger-than-expected third-quarter earnings, driven by robust growth in its oncology business.
Core earnings per share came in at $2.79 (+19% at constant exchange rate), beating the $2.62
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
